Clinical Trial

A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety, the tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of ENERGI-F705 Tablets in healthy subjects.
Trial Details
NCT Number NCT07650383
Lead Sponsor Energenesis Biomedical Co., Ltd.
Conditions Health Adult Subjects
Enrollment 24 participants
Start Date 2025-02-24
Primary Completion 2025-05-06 (estimated)
Study Completion 2025-11-19 (estimated)
Updated on ClinicalTrials.gov 2026-06-16